hydralazine has been researched along with Persistent Fetal Circulation Syndrome in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Persistent Fetal Circulation Syndrome: A syndrome of persistent PULMONARY HYPERTENSION in the newborn infant (INFANT, NEWBORN) without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction (reactive type), hypertrophy of pulmonary arterial muscle (hypertrophic type), or abnormally developed pulmonary arterioles (hypoplastic type). The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus (DUCTUS ARTERIOSUS, PATENT) and at times a patent foramen ovale (FORAMEN OVALE, PATENT).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morisot, C | 1 |
Dubos, JP | 1 |
Kacet, N | 1 |
Gremillet, C | 1 |
Remy-Jardin, M | 1 |
Lequien, P | 1 |
1 other study available for hydralazine and Persistent Fetal Circulation Syndrome
Article | Year |
---|---|
Neonatal hypertension and thrombosis of the ductus arteriosus.
Topics: Acebutolol; Captopril; Child, Preschool; Ductus Arteriosus; Female; Follow-Up Studies; Humans; Hydra | 1991 |